V ascular calcification is a frequent complication in patients with diabetes mellitus and chronic kidney disease (CKD) 1 and predicts an increased risk of mortality and cardiovascular events. 2 Advanced glycation end products (AGE) represent a group of heterogeneous compounds that are formed through nonenzymatic glycation and oxidation of proteins and lipids after exposure to aldose sugars 3, 4 and frequently accumulate in diabetes mellitus 5 and renal failure. 6, 7 The accumulation of AGE has been suggested to play an important role in inflammation and atherosclerosis. 8, 9 Recent experimental data showed that tissue AGE may induce calcification of vascular smooth muscle cells through the receptor for AGE (RAGE)/ p38 mitogen-activated protein kinase signaling pathway. 10 The skin autofluorescence reader is a recently developed noninvasive device that measured fluorophore of ultraviolet-A spectrum. Skin autofluorescence is determined from the ratio between the emission fluorescence in the wavelength range of 420 to 600 nm and the reflected excitation light with a wavelength range of 300 to 420 nm measured using a spectrometer and AGE reader software. In this wavelength band, the major contribution in fluorescence comes from fluorescent AGEs linked mostly not only to collagen but also to other proteins and lipids. Thus, skin autofluorescence is a group reactivity, reflecting total skin AGE pool rather than an individual fluorophore. Skin autofluorescence has been validated against AGE measurements from skin biopsy and shown to correlate reasonably well with skin AGE residues, including N-carboxymethyllysine, pentosidine, and N-carboxyethyllysine (r=0.47-0.62; P≤0.002) in patients with diabetes mellitus and in hemodialysis patients. [11] [12] [13] Skin autofluorescence assessment is broadly applicable and has been shown to predict the development of microvascular disease 5 and cardiac mortality in type 2 diabetes mellitus. 14 Uremia may contribute to increased oxidative stress and inflammation, thus inducing protein and lipid modification, which contributes to increased AGE formation. 15, 16 Indeed, elevated skin autofluorescence has also been shown to predict an increased mortality in hemodialysis patients. 13 Given this background, the current prospective study aims to investigate determinants of skin autofluorescence and evaluate whether skin autofluorescence, as a measure of tissue AGE accumulation and cumulative metabolic stress, may be associated with vascular calcification in patients with nondialysis CKD.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Baseline Characteristics
Of the 300 patients recruited, 10 were excluded from skin autofluorescence assessment because of dark skin. No other patients have other artifacts on forearm site that precluded skin autofluorescence assessment. The background causes of kidney disease in the 290 patients included 78 chronic glomerulonephritis (26.9%), 82 diabetic nephropathy (28.3%), 27 hypertensive nephrosclerosis (9.3%), 24 polycystic kidney disease (8.3%), 7 obstructive uropathy (2.4%), 1 tubulointerstitial disease (0.3%), and 71 unidentified causes (24.5%). Table 1 presents baseline characteristics of the study cohort. The mean estimated glomerular filtration rate (eGFR) of the cohort was 33.1±17.7 mL/min per 1.73 m 2 with 146 (50.4%), 92 (31.7%), and 52 (17.9%) patients having stage 3, 4, and 5 CKD, respectively. The mean±SD skin autofluorescence was 2.58±0.58 arbitrary units (AU) with men and women having similar levels (2.57±0.66 and 2.61±0.48 AU, respectively). The skin autofluorescence was significantly higher in patients with underlying diabetes mellitus (2.81±0.66 AU) versus those without (2.41±0.45 AU; P<0.001). The median coronary artery calcium score (CACS) was 41 (range, 0-3881). Table I in the online-only Data Supplement presents univariate linear regression analysis of skin autofluorescence. Using multiple linear regression analysis, increasing age (P<0.001), diabetes mellitus (P<0.001), smoking (P=0.006), and eGFR (P=0.004) were the 4 most significant factors associated with skin autofluorescence (model 1; Table 2 ). However, eGFR was displaced when intact parathyroid hormone (PTH) was included in the model (P<0.001; model 2; Table 2 ). Figure 1A depicts mean skin autofluorescence in relation to CKD stages and diabetes mellitus status of patients. Skin autofluorescence showed significant increase with worsening CKD stages and diabetes mellitus (P<0.001). We stratified patients by tertiles of intact PTH, namely ≤6.94 pmol/L, between 6.95 and 12.50 pmol/L, and ≥12.51 pmol/L. A significant increase in skin autofluorescence was observed across the tertiles of intact PTH (P<0.001; Figure 1B ). Figure 1C displays mean skin autofluorescence in relation to diabetes mellitus status and tertiles of intact PTH. Skin autofluorescence was the highest among patients with diabetes mellitus and in the upper tertile of intact PTH. Table 3 details the characteristics of patients in relation to the degree of CACS stratified into 4 groups, namely CACS =0, ≥1 to 99, ≥100 to 399, and ≥400. We observed a significant increasing trend in age (P<0.001), % of men (P<0.001), prevalence of diabetes mellitus (P<0.001), background atherosclerotic vascular disease (P<0.001), coronary artery disease (P<0.001), and heart failure (P<0.001) across the 4 groups of patients with increasing CACS. A significant increase in skin autofluorescence was observed across the 4 groups of patients with increasing CACS (P<0.001). Figure 2A shows the degree of coronary artery calcification in relation to tertiles of skin autofluorescence. Of the various biochemical parameters, a significant declining trend in eGFR (P=0.001) and low-density lipoprotein cholesterol (P=0.001) and an increasing trend in fasting glucose (P<0.001) and triglyceride (P=0.015) were observed across the 4 groups of patients with increasing CACS. No significant association was observed between plasma calcium, phosphate, and alkaline phosphatase with the degree of CACS. A trend toward increasing intact PTH was observed across the 4 groups of patients with increasing CACS but not reaching statistical significance (P=0.1). Figure 2B shows the prevalence of different degree of CACS in relation to tertiles of intact PTH and diabetes mellitus status. C-reactive protein, systolic and diastolic blood pressure, lowdensity lipoprotein cholesterol, and triglyceride other than age and sex, every 1-U increase in skin autofluorescence was associated with a 3.60-fold increased odds (95% CI, 1.43-9.07; P=0.006) of having CACS ≥400 compared with reference group (model 2). Additionally adjusting for eGFR did not reduce the association between skin autofluorescence and CACS ≥400 (odds ratio, 3.62; 95% CI, 1.42-9.22; P=0.007; model 3). Further adjusting for intact PTH did not reduce the association between skin autofluorescence and CACS ≥400 (odds ratio, 3.82; 95% CI, 1.47-9.90; P=0.006; model 4). However, further adjusting for fasting glucose reduced the association between skin autofluorescence and CACS ≥400 (odds ratio, 3.49; 95% CI, 1.34-9.09; P=0.01; model 5). The association between skin autofluorescence and CACS ≥400 lost significance (odds ratio, 2.21; 95% CI, 0.79-6.16; P=0.1) when additionally adjusting for diabetes mellitus (model 7; Table 4 ). 
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Using receiver-operator characteristics curve analysis, the area under the curve in predicting CACS ≥400 was 0.71 (95% CI, 0.65-0.76) for skin autofluorescence (P<0.0001) and was much higher compared with other biochemical parameters of CKDmineral bone disease (Figure 3) . The skin autofluorescence level that best predicted patients with CACS ≥400 was 2.76 AU with a sensitivity of 56.1% and a specificity of 78.1%. The positive predictive value associated with skin autofluorescence level of 2.76 was 43% and negative predictive value was 85.8%.
Discussion
To the best of our knowledge, this study is the first to demonstrate an important link between skin autofluorescence, reflecting tissue AGE accumulation, and CACS in patients with stage 3 to 5 CKD. Notably, the combination of diabetes mellitus and stage 5 CKD was associated with the highest skin autofluorescence and highest CACS. Skin autofluorescence retained independent, significant association with CACS ≥400 when adjusting for age, sex, blood pressure, plasma calcium, phosphate, intact PTH, albumin, high-sensitivity C-reactive protein, low-density lipoprotein cholesterol, triglyceride, fasting glucose, and eGFR. However, the association was lost when additionally adjusting for diabetes mellitus. These data suggest that AGE may contribute to vascular calcification in CKD and diabetes mellitus. Skin autofluorescence has been shown to correlate well with skin level of AGE residues, including N-carboxymethyllysine, pentosidine, and N-carboxyethyllysine, 11, 12 and predict an increased mortality in hemodialysis patients 13 and in patients with diabetes mellitus. 14 Experimental studies showed that AGE is capable of inducing osteoblast-like differentiation and calcification of vascular smooth muscle cells through the RAGE/p38 mitogen-activated protein kinase signaling pathway. 17, 18 Similarly, another study showed an increased expression of RAGE and typical bone proteins, including osteopontin and alkaline phosphatase in conjunction with increased calcium accumulation in rat aortic vascular smooth muscle cells incubated with AGE in a time-and dose-dependent manner. These AGE-mediated changes in vascular smooth muscle cells were partially attenuated by a neutralizing antibody to RAGE. 19 AGE has also been shown to accelerate vascular calcification through the RAGE/ oxidative stress pathway in an animal model of diabetic vascular calcification. 20 Thus, our current novel clinical observations add to the growing experimental evidence linking AGE to vascular calcification and support the involvement of tissue AGE in the process of vascular calcification in CKD and diabetes mellitus. In keeping with our findings, a previous study showed that plasma AGE (as denoted by pentosidine level) together with lipid peroxides (indicating oxidative stress) was linked to coronary artery calcification in dialysis patients. 21 The other key finding is the important novel association between intact PTH and skin autofluorescence. Intact PTH displaced eGFR as the third most significant correlate of skin autofluorescence after age and diabetes mellitus. Notably, when stratifying patients into subgroups according to the presence or absence of diabetes mellitus and level of intact PTH, the combination of diabetes mellitus and intact PTH of the upper tertile was clearly associated with the highest skin autofluorescence and CACS. There is preliminary suggestion that AGE collagen cross-links was associated with disorders of bone mineralization in dialysis patients. 22 Taken together, our findings demonstrate an important link between AGE, intact PTH, diabetes mellitus, and vascular calcification that warrants further elucidation.
As shown by our data and others, 5, 6, 13 diabetes mellitus was one of the strongest determinants of skin autofluorescence. Hyperglycemia drives the nonenzymatic reaction between proteins and glucose in the Maillard reaction to form AGE. 23 AGE may be formed during oxidative stress involving reactive carbonyl compounds. 15, 24 AGE may also accumulate as a result of ingestion of food with high AGE content 25 or impaired renal clearance. 26 In keeping with a number of studies showing an important relationship between worsening kidney function and increased skin autofluorescence, 6, 27, 28 we observed a significant inverse association between eGFR and skin autofluorescence. Given the cross-sectional study design, it is currently not known whether an increased skin autofluorescence with worsening eGFR may be attributed to decreased renal AGE clearance or increased production through dicarbonyl and oxidative stress. Our results showed that the combination of diabetes mellitus and CKD was associated with the highest skin autofluorescence than either factor alone. Tissue AGE accumulation may further cross-link with proteins such as collagens and interact with RAGE, leading to activation of intracellular signaling pathways with cytokine release, inflammation, and tissue damage. 29 RAGE has been implicated as playing a pathogenic role in CKD and cardiovascular disease. 30, 31 Skin autofluorescence is a strong and independent predictor of overall and cardiovascular mortality in hemodialysis patients and has been inversely correlated with circulating endothelial progenitor cells 32 and positively associated with arterial stiffness in patients with end-stage renal disease. 6, 13 A recent systematic review also reported positive associations between skin autofluorescence and various diabetic complications, including nephropathy, neuropathy, and other macrovascular complications except retinopathy. 33 In our current study, diabetes mellitus and skin autofluorescence showed strong associations with vascular calcification. More than 70% of patients with CACS ≥400 were diabetics. Skin autofluorescence was the highest among diabetic CKD patients with CACS ≥400. However, the association between skin autofluorescence and CACS was lost when additionally adjusting for diabetes mellitus. These findings provide important novel evidence that vascular calcification may underlie the important associations between increased skin autofluorescence with adverse overall and cardiovascular outcomes in patients with CKD and diabetes mellitus. There is evidence that skin autofluorescence may qualify as a better marker of cumulative metabolic stress and tissue AGE accumulation than circulating AGE levels 11 and specifically reflects tissue AGEs, including pentosidine, N-carboxymethyllysine, and N-carboxyethyllysine. 11 Preliminary analysis from our receiveroperator characteristics curve analysis also suggests that skin autofluorescence may be useful in predicting CACS ≥400.
In this study, age was one of the most important determinants of skin autofluorescence. The linear association between increasing chronological age and skin autofluorescence was previously reported in healthy individuals 34, 35 and other CKD cohorts. 6, 13 However, our study did not observe any significant relations between individual biochemical parameters of CKDmineral bone disease, including serum calcium, phosphate, and alkaline phosphatase with vascular calcification. The exact explanation is not clear but may be explained by one-off time point sampling of various biochemical parameters that did not reflect cumulative burden of disordered mineral metabolism.
Our study has several limitations. First, we cannot make causal inferences based on the cross-sectional study design. Second, the current skin autofluorescence reader cannot be applied to patients with dark skin. However, this accounted for <1% in our study. Third, we did not have data on albuminuria.
In conclusion, our results provide important novel evidence linking skin autofluorescence, a proxy of tissue AGE, to vascular calcification in CKD and diabetes mellitus and support AGE playing a role in vascular calcification in CKD and diabetes mellitus that warrant further experimental investigation. Longitudinal study is needed to determine whether tissue AGE may predict progression of vascular calcification in CKD.
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